New studies that popped up in Clinical Trials.gov looking at Pharmasett's PSI-7977 with and without Peg in Genotypes 1, 2, 3, 4 and 5. Many thanks to the good people over at NATAP.org for the heads' up on these trials.
PSI-7977 With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 (ATOMIC)
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment